Rankings
▼
Calendar
ATYR FY 2025 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena
ATYR
aTyr Pharma, Inc.
$93M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$190,000
-19.1% YoY
Gross Profit
-$1M
-717.4% margin
Operating Income
-$78M
-40856.3% margin
Net Income
-$74M
-39009.5% margin
EPS (Diluted)
$-0.80
Cash Flow
Operating Cash Flow
-$62M
Free Cash Flow
-$62M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$93M
Total Liabilities
$27M
Stockholders' Equity
$67M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$190,000
$235,000
-19.1%
Gross Profit
-$1M
$235,000
-680.0%
Operating Income
-$78M
-$68M
-14.3%
Net Income
-$74M
-$64M
-15.8%
← Q4 2024
All Quarters
Q1 2025 →